<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.116379</article-id><article-id pub-id-type="publisher-id">ACM-43079</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210600000_56563013.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  对比增强能谱乳腺X线摄影的临床应用进展
  Progress in Clinical Application of Contrast Enhanced Energy Spectrum Mammography
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>蔡</surname><given-names>文清</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>霍</surname><given-names>善棋</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>廖</surname><given-names>发超</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>姚</surname><given-names>虹</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>陈</surname><given-names>志明</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>云南省第一人民医院放射科，云南 昆明</addr-line></aff><aff id="aff2"><addr-line>大理大学临床医学院，云南 大理；云南省第一人民医院放射科，云南 昆明</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>01</day><month>06</month><year>2021</year></pub-date><volume>11</volume><issue>06</issue><fpage>2628</fpage><lpage>2632</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  对比增强能谱乳腺X线摄影(CESM)是近年来新兴的影像学技术，在乳腺病变的诊断领域正在迅速发展。它结合了全数字化乳腺摄影(FFDM)与静脉注射碘对比剂，在提供肿瘤形态影像的同时，又可提供肿瘤灌注信息。CESM的诊断效能较传统乳腺X线有所提高，相比于乳腺MRI诊断价值相似并且成本更低，检查时间更短。本文就CESM的原理及临床应用进展进行综述。
   Contrast enhanced energy spectrum mammography (CESM) is a new imaging technology in recent years, which is developing rapidly in the field of breast disease diagnosis. It combines full digital mammography (FFDM) with intravenous iodine contrast agent. It can provide tumor perfusion information as well as tumor morphological images. The diagnostic efficiency of CESM is higher than that of traditional mammography. Compared with breast MRI, CESM has similar diagnostic value, lower cost and shorter examination time. This article reviews the principle and clinical application of CESM.
 
</p></abstract><kwd-group><kwd>对比增强能谱乳腺X线摄影，乳腺癌，磁共振成像, Contrast Enhanced Energy Spectrum Mammography</kwd><kwd> Breast Cancer</kwd><kwd> Magnetic Resonance Imaging</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>对比增强能谱乳腺X线摄影(CESM)是近年来新兴的影像学技术，在乳腺病变的诊断领域正在迅速发展。它结合了全数字化乳腺摄影(FFDM)与静脉注射碘对比剂，在提供肿瘤形态影像的同时，又可提供肿瘤灌注信息。CESM的诊断效能较传统乳腺X线有所提高，相比于乳腺MRI诊断价值相似并且成本更低，检查时间更短。本文就CESM的原理及临床应用进展进行综述。</p></sec><sec id="s2"><title>关键词</title><p>对比增强能谱乳腺X线摄影，乳腺癌，磁共振成像</p></sec><sec id="s3"><title>Progress in Clinical Application of Contrast Enhanced Energy Spectrum Mammography</title><p>Wenqing Cai<sup>1,2</sup>, Shanqi Huo<sup>2</sup>, Fachao Liao<sup>2</sup>, Hong Yao<sup>2</sup>, Zhiming Chen<sup>2*</sup></p><p><sup>1</sup>Clinical Medical College of Dali University, Dali Yunnan</p><p><sup>2</sup>Department of Radiology, Yunnan First People’s Hospital, Kunming Yunnan</p><p><img src="//html.hanspub.org/file/21-1572280x4_hanspub.png" /></p><p>Received: May 10<sup>th</sup>, 2021; accepted: May 29<sup>th</sup>, 2021; published: Jun. 11<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/21-1572280x5_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Contrast enhanced energy spectrum mammography (CESM) is a new imaging technology in recent years, which is developing rapidly in the field of breast disease diagnosis. It combines full digital mammography (FFDM) with intravenous iodine contrast agent. It can provide tumor perfusion information as well as tumor morphological images. The diagnostic efficiency of CESM is higher than that of traditional mammography. Compared with breast MRI, CESM has similar diagnostic value, lower cost and shorter examination time. This article reviews the principle and clinical application of CESM.</p><p>Keywords:Contrast Enhanced Energy Spectrum Mammography, Breast Cancer, Magnetic Resonance Imaging</p><disp-formula id="hanspub.43079-formula19"><graphic xlink:href="//html.hanspub.org/file/21-1572280x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/21-1572280x8_hanspub.png" /> <img src="//html.hanspub.org/file/21-1572280x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>乳腺癌(Breast Cancer)是全球女性最常见的恶性肿瘤，已成为威胁女性生命安全的重大健康问题。近年来，恶性肿瘤早期筛查、早诊早治的重要性逐渐被越来越多的人们所认识，根据统计表明，乳腺癌患者在发生晚期远处器官转移之前，约70%~80%的早期非转移性乳腺癌患者是可以被治愈的 [<xref ref-type="bibr" rid="hanspub.43079-ref1">1</xref>]。目前，常规的乳腺癌影像学诊断技术包括乳腺X线摄影、MRI及乳腺超声，其中乳腺X线摄影(mammography, MG)检查是乳腺癌筛查和诊断的首选影像技术。中国拥有大量致密型乳腺的女性乳腺癌患者，因致密型乳腺的高腺体密度，使得乳腺钼靶对其的诊断准确性有所下降 [<xref ref-type="bibr" rid="hanspub.43079-ref2">2</xref>]。对比增强能谱乳腺X线摄影(contrast-enhanced spectral mammography, CESM)是近年来兴起的新成像技术，它结合了全数字化乳腺摄影(FFDM)与静脉注射碘对比剂，在提供肿瘤形态影像的同时，又可提供肿瘤灌注的功能学信息，CESM的独特优势为乳腺病变的影像诊断提供新的选择。本文将对CESM的临床应用进展现状进行综述。</p></sec><sec id="s6"><title>2. CESM技术的概述</title><p>全数字化乳腺摄影(full-field digital mammography, FFDM)虽然对脂肪型腺体的敏感性较高，但由于自身成像模式的局限性，对于中国女性常见的致密型乳腺进行诊断时容易造成假阴性或假阳性结果的出现 [<xref ref-type="bibr" rid="hanspub.43079-ref3">3</xref>]。对比增强能谱乳腺X线摄影(CESM)通过利用造影剂在恶性肿瘤新生血管区域的高积聚，展现出独特的成像优势。这项技术在2011年获得了FDA的批准用于临床应用。</p><p>CESM运用了碘化造影以及双能量采集技术，可获得基于恶性肿瘤新生血管形成的形态以及生理信息。双能量采集又称双能剪影技术，原理是碘造影剂在K-edge (33.2 keV)的边缘效应，在对比剂注射之后分别采集低能(低于33.2 keV)和高能(高于33.2 keV) X线图像，低能图拥有和FFDM相似的形态细节，高能图则可突出对比度吸收区域。利用碘和乳腺组织在这两个能级的X射线衰减差异来抑制背景乳腺组织，并对低能和高能图像进行特定的加权重组，得到剪影图像，以最大限度地提高病变中低浓度碘的可见性。因此对于CESM的检查设备，除了乳房X光检查中常用的钼和铑过滤器外，还添加了一种新的铜质过滤片。</p><p>CESM检查所注射的对比剂为与CT成像相似的低渗碘对比剂，注射剂量为1.5 mL/kg体重(最高的总注射剂量通常不超过150 ml)，浓度为300~350 mg/ml，速度为2~3 ml/s。在对比剂注射后延迟两分钟开始低能(26到30 kVp)到高能(45到49 kVp)图像的采集，有利于对比剂吸收进去到组织中。双能量采集系统最终采集到的图像包括每个乳房的标准头尾位(craniocaudal, CC)和内外斜位(mediolateral oblique, MLO)的4张低能图与4张减影图 [<xref ref-type="bibr" rid="hanspub.43079-ref4">4</xref>]。</p></sec><sec id="s7"><title>3. CESM的临床应用</title><p>近年来，对比增强能谱乳腺X线摄影(CESM)的临床应用日益增加。CESM在评估乳腺疾病方面表现出与MRI几乎相当的准确性及灵敏性，但阳性预测值(PPV)较高，背景强化较小，CESM同时可以显著降低检查时间，并且成本更低 [<xref ref-type="bibr" rid="hanspub.43079-ref5">5</xref>]。因此CESM现在正被用来代替MRI用于提供多种诊断指标，包括评估其他检查的异常结果、提高乳腺癌的诊断效能以及新辅助化疗相关的评估。</p><sec id="s7_1"><title>3.1. 评估其他检查的异常结果</title><p>常规的乳腺X线摄影(MG)在诊断致密型乳腺时存在局限性，MRI可以极大地提高诊断灵敏性，但其特异性较低，同时人们也在寻找当存在禁忌症或者没有条件进行MRI检查的情况下的替代检查方法。在一项针对121名已在MG或超声检查中发现异常患者的报告中，患者在之后两个月内分别进行了CESM和MRI的检查，比较两种检查方法在全组和特定乳腺结构类型中的灵敏性和特异性。结果表明在全组及在致密型乳腺患者中，CESM表现出和MRI相似的结果，表明CESM可作为MRI不能提供或有MRI禁忌症的情况下的替代检查方法 [<xref ref-type="bibr" rid="hanspub.43079-ref6">6</xref>]。在另一项针对致密型乳腺患者的研究中，纳入了115例致密型乳腺患者的共131个病灶，将这些病灶的CESM和超声检查结果同组织学检查结果相对照，结果表明两者对致密型乳腺的诊断效果相当 [<xref ref-type="bibr" rid="hanspub.43079-ref7">7</xref>]。在一项CESM与MG对乳腺病变检查结果的对比研究中，MG漏诊恶性病变27个，其中就有25个是致密型的乳房，而在这25例中，CESM阳性的为20例(80.0%)，可见与MG相比，CESM可显著减少致密型乳腺病例的假阴性结果 [<xref ref-type="bibr" rid="hanspub.43079-ref8">8</xref>]。</p></sec><sec id="s7_2"><title>3.2. 提高乳腺癌的诊断效能</title><p>通过辅助检查对乳腺癌患者的病变严重程度评估分析，有助于临床医生准确制定后续的肿瘤治疗方案，CESM的加入为乳腺癌患者提供了一个创新性的检查选择，在近年来的相关报告中，CESM也展现出对乳腺癌极好的诊断效能。CESM的诊断基础是肿瘤组织相对于周围正常乳腺组织的表现出的异常强化影像，在2020年的一项荟萃分析中，CESM发现阳性病灶的前测概率为57%，测试后的概率为83%，而阴性发现的后测概率为20%，在MG及超声不能确定病灶严重程度及MRI禁忌症或不可用时，CESM被认为是评估乳腺癌严重程度的可靠方式 [<xref ref-type="bibr" rid="hanspub.43079-ref9">9</xref>]。乳腺癌的腋窝淋巴转移与其严重程度及预后紧密相关，国外有学者建立了基于CESM的乳腺癌腋窝淋巴结转移的放射组学诺模图，并验证其对淋巴结转移的预测效果，最终构建的诺模图对于乳腺癌腋窝淋巴结转移的灵敏度在95%以上，在乳腺癌淋巴转移的术前预测中具有良好的应用前景 [<xref ref-type="bibr" rid="hanspub.43079-ref10">10</xref>]。在一项针对乳腺癌术后患者的复发型乳腺癌的研究中，和传统X线相比，CESM将复发癌的诊断效能显著提高，灵敏度达到91.17%，特异度75%，准确率82.85%，再次表明了CESM的诊断可靠性 [<xref ref-type="bibr" rid="hanspub.43079-ref11">11</xref>]。</p></sec><sec id="s7_3"><title>3.3. 新辅助化疗相关的评估</title><p>乳腺癌患者的新辅助化疗(neoadjuvant chemotherapy, NAC)应用可以大幅度提高保乳概率，利用影像学手段评估肿瘤对NAC的反应可以了解当前NAC的有效性，发现治疗效果差的原发肿瘤，从而指导临床进行治疗策略的选择，合理安排手术时机，避免毒性反应。在2020年的一项针对NAC的荟萃分析中，作者比较对比增强磁共振成像(CE-MRI)和CESM检测NAC病理反应的准确性，结果显示，CESM与CE-MRI相比，具有同等的特异性、更高的敏感性和优异的性能，在评价乳腺癌对NAC的病理反应方面有更广阔的前景 [<xref ref-type="bibr" rid="hanspub.43079-ref12">12</xref>]。在另一项研究中，为了早期预测新NAC后的病理反应，进行了CESM增强扫描的定量分析，将经过NAC治疗并手术切除病灶的患者随机分为病理完全应答组(PCR组)和非病理完全应答组(Non-PCR组)，比较两组CGV灰度值降低百分率(Δ-CGV)是否有统计学差异。结果证明了CESM对NAC后早期评估病理反应的有效性 [<xref ref-type="bibr" rid="hanspub.43079-ref13">13</xref>]。国外一个团队设计了一种基于CESM的放射组学诺模图，用于在治疗前预测NAC不敏感的乳腺癌。该诺模图包含11个放射组学特征以及Ki-67指数、背景实质增强和人表皮生长因子受体-2 (HER-2)状态3个独立临床危险因素，结果显示其在临床应用中具有一定实用性 [<xref ref-type="bibr" rid="hanspub.43079-ref14">14</xref>]。</p></sec></sec><sec id="s8"><title>4. CESM临床应用的挑战</title><p>CESM在临床中应用日渐增多，表现出比传统MG检查更高的准确性及灵敏性，和MRI相比拥有更低的检查时间和检测成本，但其目前还存在诸多局限性限制着CESM的更进一步应用。与MG相同，CESM检查中可能会遗漏深部组织的病变或位于图像投影盲点的病变，背景实质性的增强以及非强化乳腺癌的掩蔽效应也会造成假阴性结果的出现 [<xref ref-type="bibr" rid="hanspub.43079-ref15">15</xref>]。另外，一些良性病变也存在新生血管增多的表现，在CESM上也会表现为增化表现，这造成了假阳性率的提高。由于CESM检查所注射的对比剂为与CT成像相似的低渗碘对比剂，出现碘对比剂不良反应的情况也和CT相似。CESM相比于传统的MG检测，在提高诊断能力的同时也增加了辐射剂量(100%到180%)，额外的辐射剂量与被检查乳房的厚度有关。总之，CESM自身存在的局限性可能会影响它的更广泛应用，解决这些有待于技术各方面的进一步改进提升。</p></sec><sec id="s9"><title>5. 总结</title><p>对比增强能谱乳腺X线摄影(CESM)作为新兴的影像学技术，在乳腺病变的诊断领域正在迅速发展。相比于其他检查方式，CESM拥有自身独特的优势，它在提供肿瘤形态影像的同时，又可提供肿瘤灌注的功能学信息，同时也存在自身的局限性有待进一步优化，以获得更广大应用空间。</p></sec><sec id="s10"><title>文章引用</title><p>蔡文清,霍善棋,廖发超,姚 虹,陈志明. 对比增强能谱乳腺X线摄影的临床应用进展Progress in Clinical Application of Contrast Enhanced Energy Spectrum Mammography[J]. 临床医学进展, 2021, 11(06): 2628-2632. https://doi.org/10.12677/ACM.2021.116379</p></sec><sec id="s11"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.43079-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Nadia, H., Frédérique, P.-L., Javier, C., et al. (2019) Breast Cancer. Nature Reviews Disease Primers, 5, 66.  
&lt;br&gt;https://doi.org/10.1038/s41572-019-0111-2</mixed-citation></ref><ref id="hanspub.43079-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Qin, Y., Liu, Y., Zhang, X.Q., et al. (2020) Contrast-Enhanced Spectral Mammography: A Potential Exclusion Diagnosis Modality in Dense Breast Patients. Cancer Medicine, 9, 2653-2659. &lt;br&gt;https://doi.org/10.1002/cam4.2877</mixed-citation></ref><ref id="hanspub.43079-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Patsy, W., Kulsam, A., Sarah, V., et al. (2021) Digital Breast Tomosynthesis: Sensitivity for Cancer in Younger Symptomatic Women. The British Journal of Radiology, 94, Article ID: 20201105.  
&lt;br&gt;https://doi.org/10.1259/bjr.20201105</mixed-citation></ref><ref id="hanspub.43079-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Moreno, Z., Andrea, C., Manuela, T.R., et al. (2019) Technique, Protocols and Adverse Reactions for Contrast-Enhanced Spectral Mammography (CESM): A Systematic Review. Insights Imaging, 10, 76.  
&lt;br&gt;https://doi.org/10.1186/s13244-019-0756-0</mixed-citation></ref><ref id="hanspub.43079-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Li, L., Roth, R., Germaine, P., et al. (2017) Contrast-Enhanced Spectral Mammography (CESM) versus Breast Magnetic Resonance Imaging (MRI): A Retrospective Comparison in 66 Breast Lesions. Diagnostic and Interventional Imaging, 98, 113-123. &lt;br&gt;https://doi.org/10.1016/j.diii.2016.08.013</mixed-citation></ref><ref id="hanspub.43079-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Wojciech, R., Tomasz, P., Natalia, R.-L., et al. (2021) The Effectiveness of Contrast-Enhanced Spectral Mammography and Magnetic Resonance Imaging in Dense Breasts. Polish Journal of Radiology, 86, e159-e164.  
&lt;br&gt;https://doi.org/10.5114/pjr.2021.104834</mixed-citation></ref><ref id="hanspub.43079-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Lu, Z.F., Hao, C.J., Pan, Y., et al. (2020) Contrast-Enhanced Spectral Mammography versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts. Korean Journal of Radiology, 21, 442-449.  
&lt;br&gt;https://doi.org/10.3348/kjr.2019.0393</mixed-citation></ref><ref id="hanspub.43079-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Miki, M., Sadako, A.-T., Satoko, S., et al. (2017) Diagnostic Accuracy of Contrast-Enhanced Spectral Mammography in Comparison to Conventional Full-Field Digital Mammography in a Population of Women with Dense Breasts. Breast Cancer, 24, 104-110. &lt;br&gt;https://doi.org/10.1007/s12282-016-0681-8</mixed-citation></ref><ref id="hanspub.43079-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Basilio, S.M., Filippo, P., Maria, A.G., et al. (2020) Diagnostic Accuracy of Contrast-Enhanced Spectral Mammography for Breast Lesions: A Systematic Review and Meta-Analysis. Breast, 53, 8-17.  
&lt;br&gt;https://doi.org/10.1016/j.breast.2020.06.005</mixed-citation></ref><ref id="hanspub.43079-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Mao, N., Yin, P., Li, Q., et al. (2020) Radiomics Nomogram of Contrast-Enhanced Spectral Mammography for Prediction of Axillary Lymph Node Metastasis in Breast Cancer: A Multicenter Study. European Radiology, 30, 6732-6739.  
&lt;br&gt;https://doi.org/10.1007/s00330-020-07016-z</mixed-citation></ref><ref id="hanspub.43079-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Helal, M.H., Mansour, S.M., Ahmed, H.A., et al. (2019) The Role of Contrast-Enhanced Spectral Mammography in the Evaluation of the Postoperative Breast Cancer. Clinical Radiology, 74, 771-781.  
&lt;br&gt;https://doi.org/10.1016/j.crad.2019.06.002</mixed-citation></ref><ref id="hanspub.43079-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Tang, S.D., Xiang, C.H. and Yang, Q. (2020) The Diagnostic Performance of CESM and CE-MRI in Evaluating the Pathological Response to Neoadjuvant Therapy in Breast Cancer: A Systematic Review and Meta-Analysis. The British Journal of Radiology, 93, Article ID: 20200301. &lt;br&gt;https://doi.org/10.1259/bjr.20200301</mixed-citation></ref><ref id="hanspub.43079-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Xing, D., Mao, N., Dong, J.J., et al. (2021) Quantitative Analysis of Contrast Enhanced Spectral Mammography Grey Value for Early Prediction of Pathological Response of Breast Cancer to Neoadjuvant Chemotherapy. Scientific Reports, 11, Article No. 5892. &lt;br&gt;https://doi.org/10.1038/s41598-021-85353-9</mixed-citation></ref><ref id="hanspub.43079-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Z.Y., Lin, F., Ma, H., et al. (2021) Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers. Frontiers in Oncology, 11, Article ID: 605230. &lt;br&gt;https://doi.org/10.3389/fonc.2021.605230</mixed-citation></ref><ref id="hanspub.43079-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Chandni, B., Danielle, M., Roth, R.G., et al. (2017) Contrast-Enhanced Spectral Mammography: Technique, Indications, and Clinical Applications. Academic Radiology, 24, 84-88. &lt;br&gt;https://doi.org/10.1016/j.acra.2016.08.019</mixed-citation></ref></ref-list></back></article>